Women's Health Medicine
Volume 3, Issue 5 , Pages 217-223, 1 September 2006

Treatment for menopausal symptoms

John Collins is Professor Emeritus in the Department of Obstetrics and Gynecology at McMaster University, Hamilton, Canada

Abstract 

HRT is indicated to manage problems caused when the ovaries stop producing estrogen at the menopause. Cessation of menses occurs naturally when the ovarian follicles are depleted at about 51 years of age, or following surgical removal of the ovaries with or without hysterectomy. The resulting hypogonadal state may cause symptoms and detrimental changes in estrogen target tissues, including the brain, skeleton and skin and the cardiovascular and genitourinary systems. The concentration and function of hormone receptors varies in these organs and systems; also, differences in genetics and general constitution may affect androgen production and levels of circulating estrogen. Thus, there is variation between women in the development of menopausal symptoms, in the functional reaction of the target tissues to estrogen deficiency, and in the response to HRT.

Keywords:  HRT , menopause , osteoporosis , endometrial cancer , breast cancer

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 9.95 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This article has been reproduced from: Medicine 2006; 34(1): 31–37.

PII: S1744-1870(06)70208-6

doi:10.1053/S1744-1870(06)70208-6

Women's Health Medicine
Volume 3, Issue 5 , Pages 217-223, 1 September 2006

Article Tools